Shruti Gohil
Associate Medical Director, Epidemiology & Infection Prevention, Infectious Diseases
School of Medicine
School of Medicine
Associate Professor, Infectious Diseases
School of Medicine
School of Medicine
M.D.
M.P.H.
M.P.H.
Email: skgohil@uci.edu
University of California, Irvine
333 City Park Blvd, West
City Tower Suite 400
Orange, CA 92868
333 City Park Blvd, West
City Tower Suite 400
Orange, CA 92868
Research Interests
Hospital Epidemiology, Infection Prevention, Antibiotic Stewardship, Sociodemographic and Clinical Contributors to Hospital Readmissions, and Epidemiology of Sepsis
Research Abstract
Dr. Gohil’s research is dedicated to evaluating the epidemiology of infections and designing pragmatic approaches for identifying high risk patients to prevent infections at the earliest opportunity. Her intent is to design innovative clinical decision tools in detecting and preventing multidrug-resistant organism and healthcare-associated infections (HAIs) across care settings.
She has led the INSPIRE Trials, a set of 4 separate cluster randomized trials in the HCA Healthcare system evaluating risk-based electronic prompts to identify patients at high risk for antibiotic resistant infections when hospitalized with pneumonia, urinary tract infection, abdominal infections, and skin/soft tissue infection. For these trials, which involved over 150 hospitals and over 900,000 admissions, she developed risk prediction models using patient characteristics that could easily be integrated into the electronic health record for real-time clinical decision support. These trials have contributed to the field of antibiotic stewardship by demonstrating the ability of risk-based clinical decision support to successfully reducing empiric extended-spectrum antibiotic use, defining a threshold for what level of risk should be considered “high” risk for antibiotic resistant infections, and helping to reframe physician risk perceptions using absolute risk estimates in clinical decision support. Through this work, Dr. Gohil is highly conversant with large-scale data evaluation and modeling, designing electronic health record interventions for clinical decision support, and trial implementation,
Dr. Gohil also has a specific interest in improving access to preventive care in post-discharge settings by building scalable digital infection prevention tools that can reach broad populations - across care settings, training levels, and socioeconomic or geographic barriers. Her research portfolio has included developing (1) a clinical scoring tool to standardize signs/symptoms of central line infection risk and expectations for preventive actions and (2) photo-surveillance mobile-apps for lines and wounds that provides patients, nurses, and physicians a platform for communication of scores and photos and a digital pathway for direct care across care transitions. Through these efforts, she has built a large digital photobank of patients with central lines and surgical wounds that will be used to design artificial intelligence surveillance systems capable of early detection of high-risk central lines and surgical wounds to prevent progression to bloodstream and surgical site infections.
She has led the INSPIRE Trials, a set of 4 separate cluster randomized trials in the HCA Healthcare system evaluating risk-based electronic prompts to identify patients at high risk for antibiotic resistant infections when hospitalized with pneumonia, urinary tract infection, abdominal infections, and skin/soft tissue infection. For these trials, which involved over 150 hospitals and over 900,000 admissions, she developed risk prediction models using patient characteristics that could easily be integrated into the electronic health record for real-time clinical decision support. These trials have contributed to the field of antibiotic stewardship by demonstrating the ability of risk-based clinical decision support to successfully reducing empiric extended-spectrum antibiotic use, defining a threshold for what level of risk should be considered “high” risk for antibiotic resistant infections, and helping to reframe physician risk perceptions using absolute risk estimates in clinical decision support. Through this work, Dr. Gohil is highly conversant with large-scale data evaluation and modeling, designing electronic health record interventions for clinical decision support, and trial implementation,
Dr. Gohil also has a specific interest in improving access to preventive care in post-discharge settings by building scalable digital infection prevention tools that can reach broad populations - across care settings, training levels, and socioeconomic or geographic barriers. Her research portfolio has included developing (1) a clinical scoring tool to standardize signs/symptoms of central line infection risk and expectations for preventive actions and (2) photo-surveillance mobile-apps for lines and wounds that provides patients, nurses, and physicians a platform for communication of scores and photos and a digital pathway for direct care across care transitions. Through these efforts, she has built a large digital photobank of patients with central lines and surgical wounds that will be used to design artificial intelligence surveillance systems capable of early detection of high-risk central lines and surgical wounds to prevent progression to bloodstream and surgical site infections.
Awards and Honors
2006 Outstanding Resident Teacher of the Year, Internal Medicine, Univ. of California, Davis
2010 Top Abstract in Clinical Research, Infectious Disease Society of New York
2010 Travel Award, Infectious Disease Society of America
2010 Best Research Poster Award, Second Place, Montefiore Medical Center
2011 Top Abstract, Young Investigator’s Symposium, Albert Einstein College of Medicine
2013 Outstanding Attending Teacher of the Year, Internal Medicine Residency Program, Univ. of California, Irvine
2015 Program Innovation Abstract Award, Second Place, 15th International Meeting on Simulation in Healthcare
2016 SOAR Award, Nosocomial C. difficile Infection Reduction Project. UC Irvine Health
2017- 2025 NIH Loan Repayment Program Award
2017 ID Week Program Committee Choice Award. Plenary Presentation. SHEA Featured Oral Abstract, “The CDC SHIELD Orange County Project – Baseline Multi Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region,” IDWeek (6th Annual Joint Meeting of IDSA, SHEA, HIVMA, and PIDS), October 6, 2017 (San Diego, CA).
2018 Outstanding Achievement, Epidemiology & Infection Prevention, conferred by Chief Nursing Officer, UC Irvine Health
2018 Department of Medicine Chair Research Grant Award
2020 Chief Nursing Officer Award, EIP Team, UCI Health
2020 Outstanding Service Award, Graduate Medical Education, UC Irvine School of Medicine
2021 ARIISE Award Accountability, Respect, Integrity, Innovation, Service and Excellence, EIP Team, UCI Health
2021 Investigator Award Infectious Diseases Society of America & Society for Healthcare Epidemiologists of America Joint Conference (ID Week) – INSPIRE Pneumonia & Urinary Tract Infection Trials
2022 Blue Ribbon Award for Exemplary Scientific Merit, Association for Professionals in Infection Control National Conference, June 2022
2023 Women in Technology Award, UC Irvine
2024 Program Committee Choice Abstract Award, Infectious Diseases Society of America & Society for Healthcare Epidemiologists of America and Joint Conference (ID Week, October, 2024) – INSPIRE Abdominal Infection Trial.
2025 Rising Star Award 2025-2026, conferred by UC Irvine School of Medicine, UC Irvine Health to honor research faculty whose contributions embody UCI’s mission to “Discover, Teach, Heal”
2026 Top 20 Clinical Research Achievement Award in the United States for 2025-2026, conferred for the INSPIRE Abdominal Infection Trial (JAMA Surgery, 2025) by the Clinical Research Forum to honor groundbreaking achievement in research from across the nation and identify major advances in the biomedical field.
2010 Top Abstract in Clinical Research, Infectious Disease Society of New York
2010 Travel Award, Infectious Disease Society of America
2010 Best Research Poster Award, Second Place, Montefiore Medical Center
2011 Top Abstract, Young Investigator’s Symposium, Albert Einstein College of Medicine
2013 Outstanding Attending Teacher of the Year, Internal Medicine Residency Program, Univ. of California, Irvine
2015 Program Innovation Abstract Award, Second Place, 15th International Meeting on Simulation in Healthcare
2016 SOAR Award, Nosocomial C. difficile Infection Reduction Project. UC Irvine Health
2017- 2025 NIH Loan Repayment Program Award
2017 ID Week Program Committee Choice Award. Plenary Presentation. SHEA Featured Oral Abstract, “The CDC SHIELD Orange County Project – Baseline Multi Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region,” IDWeek (6th Annual Joint Meeting of IDSA, SHEA, HIVMA, and PIDS), October 6, 2017 (San Diego, CA).
2018 Outstanding Achievement, Epidemiology & Infection Prevention, conferred by Chief Nursing Officer, UC Irvine Health
2018 Department of Medicine Chair Research Grant Award
2020 Chief Nursing Officer Award, EIP Team, UCI Health
2020 Outstanding Service Award, Graduate Medical Education, UC Irvine School of Medicine
2021 ARIISE Award Accountability, Respect, Integrity, Innovation, Service and Excellence, EIP Team, UCI Health
2021 Investigator Award Infectious Diseases Society of America & Society for Healthcare Epidemiologists of America Joint Conference (ID Week) – INSPIRE Pneumonia & Urinary Tract Infection Trials
2022 Blue Ribbon Award for Exemplary Scientific Merit, Association for Professionals in Infection Control National Conference, June 2022
2023 Women in Technology Award, UC Irvine
2024 Program Committee Choice Abstract Award, Infectious Diseases Society of America & Society for Healthcare Epidemiologists of America and Joint Conference (ID Week, October, 2024) – INSPIRE Abdominal Infection Trial.
2025 Rising Star Award 2025-2026, conferred by UC Irvine School of Medicine, UC Irvine Health to honor research faculty whose contributions embody UCI’s mission to “Discover, Teach, Heal”
2026 Top 20 Clinical Research Achievement Award in the United States for 2025-2026, conferred for the INSPIRE Abdominal Infection Trial (JAMA Surgery, 2025) by the Clinical Research Forum to honor groundbreaking achievement in research from across the nation and identify major advances in the biomedical field.
Short Biography
Dr. Shruti K. Gohil, a board-certified UCI Health specialist in infectious diseases, is the associate medical director for UCI Health Epidemiology and Infection Prevention. Her clinical interests include hospital epidemiology, infection prevention, communicable disease transmission and multidrug resistant organism infections.
She led the UCI Health response to the novel coronavirus pandemic, including the clinical and epidemiologic assessment of healthcare providers and patients, COVID-19 testing and vaccination, exposure definition and response, contact tracing, vaccination and infection prevention strategies to limit viral spread.
Gohil earned her medical degree and a master's in public health from Tufts University School of Medicine in Boston, Mass. She completed an internal medicine residency at the UC Davis School of Medicine, followed by a clinical and research fellowship in infectious diseases at the Albert Einstein School of Medicine and Montefiore Medical Center in New York City.
The author or co-author of more than a 40 peer-reviewed publications, Gohil has focused her research on understanding what puts individuals and populations at risk for infectious diseases and ways to mitigate that risk as quickly as possible. This includes devising innovative ways to evaluate, detect and intervene in the spread of healthcare-associated infections. Her novel scoring system, which standardized how central lines are assessed, changed clinical responses and dramatically reduced infection risk at participating hospitals, clinical facilities and nursing homes. She also has led statewide population studies to help reduce the risk of infection-related hospital readmissions and sepsis.
She currently leads several national studies to assess patient risk for multidrug-resistant bacterial infections and to prompt physicians to limit the use of extended-spectrum antibacterial drugs in real time. These include the INSPIRE Trials, a series of 4 large-scale, randomized controlled trials to improve antibiotic selection in patients hospitalized for the top 4 most common infections for which patients are hospitalized: pneumonia, urinary tract infection, abdominal infections, and skin/soft tissue infections.
She is the recipient of the Investigator Award (2021) and Program Committee Choice Abstract Award (2024) by the Infectious Diseases Society of America & Society for Healthcare Epidemiologists of America National Conference. She is a member of the National Institutes of Health Pragmatic Trials Collaboratory and the US Food and Drug Administration’s Clinical Trials Transformation Initiative.
She led the UCI Health response to the novel coronavirus pandemic, including the clinical and epidemiologic assessment of healthcare providers and patients, COVID-19 testing and vaccination, exposure definition and response, contact tracing, vaccination and infection prevention strategies to limit viral spread.
Gohil earned her medical degree and a master's in public health from Tufts University School of Medicine in Boston, Mass. She completed an internal medicine residency at the UC Davis School of Medicine, followed by a clinical and research fellowship in infectious diseases at the Albert Einstein School of Medicine and Montefiore Medical Center in New York City.
The author or co-author of more than a 40 peer-reviewed publications, Gohil has focused her research on understanding what puts individuals and populations at risk for infectious diseases and ways to mitigate that risk as quickly as possible. This includes devising innovative ways to evaluate, detect and intervene in the spread of healthcare-associated infections. Her novel scoring system, which standardized how central lines are assessed, changed clinical responses and dramatically reduced infection risk at participating hospitals, clinical facilities and nursing homes. She also has led statewide population studies to help reduce the risk of infection-related hospital readmissions and sepsis.
She currently leads several national studies to assess patient risk for multidrug-resistant bacterial infections and to prompt physicians to limit the use of extended-spectrum antibacterial drugs in real time. These include the INSPIRE Trials, a series of 4 large-scale, randomized controlled trials to improve antibiotic selection in patients hospitalized for the top 4 most common infections for which patients are hospitalized: pneumonia, urinary tract infection, abdominal infections, and skin/soft tissue infections.
She is the recipient of the Investigator Award (2021) and Program Committee Choice Abstract Award (2024) by the Infectious Diseases Society of America & Society for Healthcare Epidemiologists of America National Conference. She is a member of the National Institutes of Health Pragmatic Trials Collaboratory and the US Food and Drug Administration’s Clinical Trials Transformation Initiative.
Publications
1. Gohil, S.K., Pirofski, L. Emerging Findings in Fungal Pathogenesis. Report from the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Infectious Disease Society of America Joint Conference 2008. Journal of Invasive Fungal Infections 2009; 2:151-153.
2. Gohil, S.K., Heo, M., Schoenbaum, E., Pirofski, L. CD8+ T cells and Risk for Bacterial Pneumonia and All-Cause Mortality in HIV-Infected Women. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):191-8.
3. Yano, M. Gohil, S.K., Coleman, R., Pirofski, L 2011. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance quorum sensing. mBio 2(5):e00176-11.
4. Rohatgi, S., Gohil, S.K., Kuniholm, M., Schultz, H., Dufauda, C., Armourd, K., Badrie, S., Mailliard, R., Pirofski, L. Fc gamma receptor 3A Polymorphism and Risk for HIV-associated Cryptococcal Disease. mBio, 4(5):e00573-13.
5. Rhee, C, Gohil, S.K., Klompas, M. Regulatory Mandates for Sepsis Care – Reasons for Caution. New England Journal of Medicine. 370:1673-1676. May 1, 2014.
6. Gohil, S.K., Datta, R., Chenghua, C., Phelan, M., Nguyen, V., Rowther, A., Huang, S. Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates. Clinical Infectious Diseases. 2015 Oct 15;61(8):1235-43.
7. Gohil, S.K., Scott, S., Quan, K., Huang, S. Marked Reduction in Compliance with Central Line Insertion Practices (CLIP) When Accounting for Missing CLIP Data and Incomplete Capture of Lines. American Journal of Infection Control. 2015 Oct 27. pii: S0196-6553(15)00980-3.
8. Gohil, S.K., Okubo, S., Klish, S., Huang, S., Zahn, M. Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention. Clinical Infectious Diseases. 2016 Jan 15;62(2):166-72.
9. Gohil, S.K., Chenghua, C., Phelan, M., Rhee, C., Platt, R., Huang, S. Impact of Policies on the Rise of Sepsis Incidence, 2000-2010. Clinical Infectious Diseases. 2016 Mar 15;62 (6): 695-703.
2. Gohil, S.K., Heo, M., Schoenbaum, E., Pirofski, L. CD8+ T cells and Risk for Bacterial Pneumonia and All-Cause Mortality in HIV-Infected Women. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):191-8.
3. Yano, M. Gohil, S.K., Coleman, R., Pirofski, L 2011. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance quorum sensing. mBio 2(5):e00176-11.
4. Rohatgi, S., Gohil, S.K., Kuniholm, M., Schultz, H., Dufauda, C., Armourd, K., Badrie, S., Mailliard, R., Pirofski, L. Fc gamma receptor 3A Polymorphism and Risk for HIV-associated Cryptococcal Disease. mBio, 4(5):e00573-13.
5. Rhee, C, Gohil, S.K., Klompas, M. Regulatory Mandates for Sepsis Care – Reasons for Caution. New England Journal of Medicine. 370:1673-1676. May 1, 2014.
6. Gohil, S.K., Datta, R., Chenghua, C., Phelan, M., Nguyen, V., Rowther, A., Huang, S. Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates. Clinical Infectious Diseases. 2015 Oct 15;61(8):1235-43.
7. Gohil, S.K., Scott, S., Quan, K., Huang, S. Marked Reduction in Compliance with Central Line Insertion Practices (CLIP) When Accounting for Missing CLIP Data and Incomplete Capture of Lines. American Journal of Infection Control. 2015 Oct 27. pii: S0196-6553(15)00980-3.
8. Gohil, S.K., Okubo, S., Klish, S., Huang, S., Zahn, M. Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention. Clinical Infectious Diseases. 2016 Jan 15;62(2):166-72.
9. Gohil, S.K., Chenghua, C., Phelan, M., Rhee, C., Platt, R., Huang, S. Impact of Policies on the Rise of Sepsis Incidence, 2000-2010. Clinical Infectious Diseases. 2016 Mar 15;62 (6): 695-703.
10. Madeline, T., Nori, P., Wenzhu, M., Zukowski, E., Gohil, S.K., Sarwar, U., Weston, G., Urelly, R., Palombelli, M., Pierino, F., Parsons, V., Ehrlich, A., Ostrowsky, B., Corpuz, M., Piroski, L. Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on AllCause
30-Day Hospital Readmissions. Open Forum Infectious Diseases. 2017 May; DOI: 10.1093/ofid/ofx097.
30-Day Hospital Readmissions. Open Forum Infectious Diseases. 2017 May; DOI: 10.1093/ofid/ofx097.
11. Gohil, S.K., Singh, R., Chang, J, Gombosev, A., Tjoa, T., Zahn, M., Steger, P., Huang, S.S. Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, CA, and support for early regional strategies to limit spread. American Journal of Infection Control. 2017 July; DOI: 10.1016/j.ajic.2017.06.004
1. Gohil, S.K., Pirofski, L. Emerging Findings in Fungal Pathogenesis. Report from the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Infectious Disease Society of America Joint Conference 2008. Journal of Invasive Fungal Infections 2009; 2:151-153. (Corresponding Author)
2. Yano, M. Gohil, S.K., Coleman, R., Pirofski, L. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance quorum sensing. mBio 2(5):e00176-11. 2011
3. Gohil, S.K., Heo, M., Schoenbaum, E., Pirofski, L. CD8+ T cells and Risk for Bacterial Pneumonia and All-Cause Mortality in HIV-Infected Women. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):191-8. (Corresponding Author)
4. Rohatgi, S., Gohil, S.K., Kuniholm, M., Schultz, H., Dufauda, C., Armourd, K., Badrie, S., Mailliard, R., Pirofski, L. Fc gamma receptor 3A Polymorphism and Risk for HIV-associated Cryptococcal Disease. mBio, 4(5):e00573-13. 2013
5. Rhee, C, Gohil, S.K., Klompas, M. Regulatory Mandates for Sepsis Care – Reasons for Caution. New England Journal of Medicine. 370:1673-1676. May 1, 2014.
6. Gohil, S.K., Datta, R., Chenghua, C., Phelan, M., Nguyen, V., Rowther, A., Huang, S. Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates. Clinical Infectious Diseases. 2015 Oct 15;61(8):1235-43. (Corresponding Author)
7. Gohil, S.K., Scott, S., Quan, K., Huang, S. Marked Reduction in Compliance with Central Line Insertion Practices (CLIP) When Accounting for Missing CLIP Data and Incomplete Capture of Lines. American Journal of Infection Control. 2015 Oct 27. pii: S0196-6553(15)00980-3. (Corresponding Author)
8. Gohil, S.K., Okubo, S., Klish, S., Huang, S., Zahn, M. Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention. Clinical Infectious Diseases. 2016 Jan 15;62(2):166-72. (Corresponding Author)
9. Gohil, S.K., Chenghua, C., Phelan, M., Rhee, C., Platt, R., Huang, S. Impact of Policies on the Rise of Sepsis Incidence, 2000-2010. Clinical Infectious Diseases. 2016 Mar 15;62 (6): 695-703. (Corresponding Author).
10. Madeline, T., Nori, P., Wenzhu, M., Zukowski, E., Gohil, S.K., Sarwar, U., Weston, G., Urelly, R., Palombelli, M., Pierino, F., Parsons, V., Ehrlich, A., Ostrowsky, B., Corpuz, M., Piroski, L. Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on AllCause
30-Day Hospital Readmissions. Open Forum Infectious Diseases. 2017 May; DOI: 10.1093/ofid/ofx097.
11. Gohil, S.K., Singh, R., Chang, J, Gombosev, A., Tjoa, T., Zahn, M., Steger, P., Huang, S.S. Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, CA, and support for early regional strategies to limit spread. American Journal of Infection Control. 2017 July; DOI: 10.1016/j.ajic.2017.06.004. (Corresponding Author)
12. Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2017;23(1):48.e9-.e16.
13. Singh, RD, Jernigan, JA, Slayton, R, Stone, ND, McKinnell, JA, Miller, LG, Kleinman, K, Heim, L, Dutciuc, TD, Estevez, M, Gussin, G, Chang, J, Peterson, EM, Evans, K, Bruce Y Lee, Lee, BY, Mueller, LE, Bartsch, SM, Zahn, M, Janssen, L, Weinstein, RA, Hayden, MA, Gohil, SK, Park, S, Tam, S, Saavedra, R, Yamaguchi, Y, Custodio, H, Nguyen, J, Tjoa, T, He, J, O’Donnell, K, Coady, MH, Platt, R, Huang, SS. CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program, The CDC SHIELD Orange County Project – Baseline Multi Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region, Open Forum Infectious Diseases, Volume 4, Issue suppl_1, Fall 2017, Pages S46 S47, https://doi.org/10.1093/ofid/ofx162.109
14. McKinnell, JA, Miller, LG, Singh, RD, Mendez, J, Franco, R, Gussin, G, Chang, J, Dutciuc, TD, Saavedra, R, Kleinman, K, Peterson, EM, Evans, Heim, L, Miner, A, Estevez, M, Custodio, H, Yamaguchi, S, Nguyen, J, Varasteh, A, Launer, B, Agrawal, S, Tjoa, T, He, J, Park, S, Tam, S, Gohil, SK, Stone, ND, Steinberg, K, Montgomery, M, Beecham, N, Huang, SS. When a Home is Not a Home: MultiDrug-Resistant Organism (MDRO) Colonization and Environmental Contamination in 28 Nursing Homes (NHs), Open Forum Infectious Diseases, Volume 4, Issue suppl_1, Fall 2017, Pages S42–S43, https://doi.org/10.1093/ofid/ofx162.103
15. Quan KA, Yim J, Merrill DG, Khusbu U, Madey K, Dickey L, Dangodara AA, Rudkin SE, O’Brien M, Thompson D, Parekh N, Albers CG, Wilson WC, Thrupp L, Bittencourt, CE, Huang, SS, Gohil, SK. Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing. Infection Control and Hospital Epidemiology. 2018 May; 39(5): 625–627. (Corresponding Author)
16. McKinnell, JA, Singh, RD, Miller, LG, Saavedra, R, Heim, L, Gussin, G, Lewis, B, Estevez, M, Catuna, TD, Mouth, K, Lee, E, He, J, Kleinman, K, Shimabukuro, J, Evans, K, Bittencourt, C, Baesu, C, Gohil, SK, Park, S, Tam, S, Robinson, PA, Slayton, R, Stone, ND, Jernigan, JA, Zahn, M, Janssen, L, ODonnell, K, Weinstein, RA, Hayden, MA, Lee, BY, Mueller, LE, Bartsch, SM, Peterson, EM, Huang, SS. The SHIELD Orange County Project: A Decolonization Strategy in 35 Hospitals and Nursing Homes Reduces Multi-Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region, Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Pages S23–S24, https://doi.org/10.1093/ofid/ofz359.052
17. McKinnell, JA, Singh, RD, Miller, LG, Kleinman, K, Gussin, G, He, J, Saavedra, R, Dutciuc, TD, Estevez, M, Chang, J, Heim, L, Yamaguchi, S, Custodio, H, Gohil, SK…. Huang, SS. The SHIELD Orange County Project –Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California. Clinical Infectious Diseases. Clinical Infectious Diseases, Volume 69, Issue 9, 1 November 2019, Pages 1566–1573, https://doi.org/10.1093/cid/ciz119
18. Gohil, SK, Yim, J, Quan, K, Espinoza, M, Thompson, DJ, Kong, AP, Bahadori, B, Tjoa, T, Paiji, C, Rudkin, S, Rashid, S, Hong, SS, Dickey, L, Alsharif, MN, Wilson, WC, Amin, AN, Chang, J, Khusbu, U, and Huang, SS. Impact of a Central Line Insertion Site Assessment (CLISA) Score on Localized Insertion Site Infection to Prevent Central Line Associated Bloodstream Infection. Infection Control and Hospital Epidemiology. 2019 Nov 8:1-8. (Corresponding Author)
19. Calderwood, M. S., Deloney, V. M., Anderson, D. J., Cheng, V. C. C., Gohil, SK, Kwon, J. H., Mody, L., Monsees, E., Vaughn, V. M., Wiemken, T. L., Ziegler, M. J., & Lofgren, E. (2020). Policies and practices of SHEA Research Network hospitals during the COVID-19 pandemic. Infection Control and Hospital Epidemiology, 41(10), 1127-1135. https://doi.org/10.1017/ice.2020.303
20. Mody, L, Akinboyo, IC, Babcock, HM, Bischoff, WE, Cheng, VC, Chiotos, K, Claeys, KC, Coffey, KC, Diekema, DJ, Donskey, CJ, Ellingson, KD, Gilmartin, HM, Gohil, SK, Harris, AD, Keller, SK, Klei, EY, Krein, SL, Kwon, JH, Lauring, AS, Livorsi, DJ, Lofgren, ET, Merrill, K, Milstone, A, Monsees, EA, Morgan, DJ, Perri, LP, Pfeiffer, CD, Rock, C, Saint, S, Sickbert-Bennett ,E, Skelton, F, Suda, KJ, Talbot, TR, Vaughn VM, Weber, DJ, Wiemken, TL, Yassin. MH, Ziegler MJ, Anderson, DJ, SHEA Research Committee. COVID-19 Research Agenda for Healthcare Epidemiology. Infection Control and Hospital Epidemiology. 2021 Jan 25;1-81. doi: 10.1017/ice.2021.25.
21. Gohil, SK, Huang, SS. Community COVID-19 Incidence and Health Care Personnel COVID-19 Seroprevalence. JAMA Netw Open. 2021 Mar 1;4(3):e211575. doi: 10.1001/jamanetworkopen.2021.1575. (Corresponding Author)
22. Srinivasan, V, Gohil, SK, Abeles, SR, Yokoe, DS, Cohen, SH, Ramirez-Avila, L, Prabaker, K, de St. Maurice, AM. Finding a needle in a haystack: The hidden costs of asymptomatic testing in a low incidence setting. Infect Control. Infection Control & Hospital Epidemiology, October, 2021, 1–2. doi:10.1017/ice.2021.288.
23. Gohil, SK, Quan, KA, Madey, KM, King-Adelsohn, S, Tifrea, D, Crews, BO, Monuki, ES, Khan, S, Schubl, SD, Bittencourt, CE, Detweiler, N, Chang, W, Willis, L, Khusbu, U, Saturno, A, Rezk, SA, igueroa, C, Edwards, R, Jain, A, Assis, R, Felgner, P, Hsieh, L, Forthal, D, Wilson, WC, Stamos, MJ, Huang, SS. COVID-19 Seroprevalence Among Healthcare Professionals Accounting for Coworker Exposures and Community Characteristics. Antimicrob Resist Infect Control. 2021 Nov 22;10(1):163. doi: 10.1186/s13756-021-01031-5. (Corresponding Author)
24. Gohil, SK, Olenslager, K, Quan K, Dastur, C, Afsar, N, Chang, W, Huang, SS. Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination. JAMA Netw Open. Jul, 2021;4(7):e2115980. doi:10.1001/jamanetworkopen.2021.15980 (Corresponding Author)
25. Gussin GM, McKinnell JA, Tjoa T, Wedlock PT, He J, Chang J, Gohil SK, Miller LG, Huang SS, Lee BY. Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a Region. JAMA Netw Open. 2021 Aug 2;4(8):e2119212. doi: 10.1001/jamanetworkopen.2021.19212. PMID: 34347060; PMCID: PMC8339938
26. Mody L, Akinboyo IC, Babcock HM, Bischoff WE, Cheng VC, Chiotos K, Claeys KC, Coffey KC, Diekema DJ, Donskey CJ, Ellingson KD, Gilmartin HM, Gohil SK, Harris AD, Keller SC, Klein EY, Krein SL, Kwon JH, Lauring AS, Livorsi DJ, Lofgren ET, Merrill K, Milstone AM, Monsees EA, Morgan DJ, Perri LP, Pfeiffer CD, Rock C, Saint S, Sickbert-Bennett E, Skelton F, Suda KJ, Talbot TR, Vaughn VM, Weber DJ, Wiemken TL, Yassin MH, Ziegler MJ, Anderson DJ; SHEA Research Committee. Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. Infect Control Hosp Epidemiol. 2022 Feb;43(2):156-166. doi: 10.1017/ice.2021.25. PMID: 33487199; PMCID: PMC8160487.
27. Waldman SE, Buehring T, Escobar DJ, Gohil SK, Gonzales R, Huang SS, Olenslager K, Prabaker KK, Sandoval T, Yim J, Yokoe DS, Cohen SH. Secondary Cases of Delta Variant Coronavirus Disease 2019 Among Vaccinated Healthcare Workers With Breakthrough Infections is Rare. Clin Infect Dis. 2022 Aug 24;75(1):e895-e897. doi: 10.1093/cid/ciab916. PMID: 34694358; PMCID: PMC8574310.
28. Quan KA, Sater MRA, Uy C, Clifton-Koeppel R, Dickey LL, Wilson W, Patton P, Chang W, Samuelson P, Lagoudas GK, Allen T, Merchant L, Gannotta R, Bittencourt CE, Soto JC, Evans KD, Blainey PC, Murray J, Shelton D, Lee HS, Zahn M, Wolfe J, Madey K, Yim J, Gohil SK, Grad YH, Huang SS. Epidemiology and genomics of a slow outbreak of methicillin-resistant Staphyloccus aureus (MRSA) in a neonatal intensive care unit: Successful chronic decolonization of MRSA-positive healthcare personnel. Infect Control Hosp Epidemiol. 2022 Jun 16:1-8. doi: 10.1017/ice.2022.133. Epub ahead of print. PMID: 35706396.
29. Hsi JB, Singh RD, Pedroza R, Gussin GM, Tjoa TT, Gohil SK. Impact of Alzheimer's disease and related dementias (ADRD) on the quality of room cleaning in nursing homes. Infect Control Hosp Epidemiol. 2023 Feb 9:1-3. doi: 10.1017/ice.2023.7. Epub ahead of print. PMID: 36756757.
30. Gohil SK, de St. Maurice A, Yokoe D, Torriani FJ, Grein JD, Robinson PA, Mabalot S, Park J, Pedrani P, Platt R, Huang SS. Assessing Past vs Present COVID-19 Infection: A Survey of Criteria for Discontinuing Precautions in Asymptomatic Patients. Infect Control Hosp Epidemiology. 2024 Feb;45(2):237-240. doi: 10.1017/ice.2023.147. Epub 2023 Sep 13. (Corresponding Author)
31. Gohil SK, Septimus E, Sands KE, Blanchard EJ, Moody J, de St. Maurice A, Yokoe D, Kwon J, Grein J, Cohen S, Uslan D, Milind V, Mauricio A, Mabalot S, Coady MD, Selsebil S, Smith K, Carver B, Poland R, Perlin J, Platt J, Huang SS. COVID-19 Infection Prevention Practices That Exceed CDC Guidance: Balancing Extra Caution Against Impediments to Care. Infection Control & Hospital Epidemiology (2023), 44, 2074–2077. doi:10.1017/ice.2023.89. (Corresponding Author)
32. Rhee Y, Hayden MK, Schoeny M, Baker AW, Baker MA, Gohil S, Rhee C, Talati NJ, Warren DK, Welbel S, Lolans K, Bahadori B, Bell PB, Bravo H, Dangana T, Fukuda C, Habrock Bach T, Nelson A, Simms AT, Tolomeo P, Wolf R, Yelin R, Lin MY; CDC Prevention Epicenters Program. Impact of measurement and feedback on chlorhexidine gluconate bathing among intensive care unit patients: A multicenter study. Infect Control Hosp Epidemiol. 2023 Sep;44(9):1375-1380. doi: 10.1017/ice.2023.177. Epub 2023 Sep 13. PMID: 37700540.
33. Miller LG, McKinnell JA, Singh RD, Gussin GM, Kleinman K, Saavedra R, Mendez J, Catuna TD, Felix J, Chang J, Heim L, Franco R, Tjoa T, Stone ND, Steinberg K, Beecham N, Montgomery J, Walters D, Park S, Tam S, Gohil S, Robinson PA, Estevez M, Lewis B, Shimabukuro JA, Tchakalian G, Minor A, Torres C, Evans KD, BA, Bittencourt CE, He J, Lee E, Nedelcu C, Lu J, Agrawal S, Sturdevant SG, Peterson E, Huang SS. Nursing Home Decolonization for Infection and Hospitalization Prevention. N Engl J Med 2023 Nov 9;389(19):1766-1777. doi: 10.1056/NEJMoa2215254. Epub 2023 Oct 10. PMID: 37815935
34. Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, Rahm R, Cooper WS, Cooper M, McLean LE, Nickolay NG, Weinstein RA, Burgess LH, M H Coady MH, Rosen E, Sljivo S, Sands KE, Moody J, Vigeant J, Rashid S, Gilbert RF, Smith KN, Carver B, Poland RE, Hickok J, Sturdevant SG, Calderwood MS, Weiland A, Kubiak DW, Reddy S, Neuhauser MM, Srinivasan A, Jernigan JA, Hayden MK, Gowda A, Eibensteiner K, Wolf R, Perlin JB, Platt R, Huang SS. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial. JAMA. Published online April 19, 2024. doi:10.1001/jama.2024.6248. (Corresponding Author)
a. Editorial: Malani AN, Malani PN. Harnessing the Electronic Health Record to Improve Empiric Antibiotic Prescribing. JAMA. 2024;331(23):1993–1994. doi:10.1001/jama.2024.6554
35. Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, Rahm R, Cooper WS, Cooper M, McLean LE, Nickolay NG, Weinstein RA, Burgess LH, M H Coady MH, Rosen E, Sljivo S, Sands KE, Moody J, Vigeant J, Rashid S, Gilbert RF, Smith KN, Carver B, Poland RE, Hickok J, Sturdevant SG, Calderwood MS, Weiland A, Kubiak DW, Reddy S, Neuhauser MM, Srinivasan A, Jernigan JA, Hayden MK, Gowda A, Eibensteiner K, Wolf R, Perlin JB, Platt R, Huang SS. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial. JAMA. Published online April 19, 2024. doi:10.1001/jama.2024.6259. (Corresponding Author)
a. Summary and Comment: Winawer NH. Your Patient Doesn’t Need a Broad-Spectrum Antibiotic. NEJM Journal Watch. 2024. https://www.jwatch.org/na57398/2024/05/21/your-patient-doesnt-need-broad-spectrum-antibiotic
36. Kwon JH, Advani SD, Branch-Elliman W, Braun BI, Cheng VC, Chiotos K, Douglas P, Gohil SK, Keller SC, Klein EY, Krein SL, Lofgren ET, Merrill K, Moehring RW, Monsees E, Perri L, Scaggs Huang F, Shelly MA, Skelton F, Spivak ES, Sreeramoju PV, Suda KJ, Ting JY, Weston GD, Yassin MH, Ziegler MJ, and Mody L. A call to action: the SHEA research agenda to combat healthcare-associated infections. Infection Control & Hospital Epidemiology. 2024;45(9):1023-1040. doi:10.1017/ice.2024.125
37. Singh RD, Bahadori B, Tjoa T, Alsharif MN, Nourollahi S, Chang J, Mauricio A, Bethlahmy J, Rashid S, Saavedra R, Ashbaugh IY, Tam S, and Gohil SK. A telehealth approach to central line-associated bloodstream infection prevention activities in nursing homes: the SAFER lines program. Infection Control & Hospital Epidemiology. Published online February 3, 2025, 46 (3), 236-242. DOI: 10.1017/ice.2024.203. (Corresponding Author)
38. Mauricio A, Hsi JB, Tjoa T, Singh RD, Nourollahi S, Saavedra R, Bahadori B, Alsharif MN, Tam S, Chang J, Rashid S, and Gohil SK. Failure of timely removal of central and peripheral venous catheters after antibiotic therapy in nursing homes. Infection Control & Hospital Epidemiology. Published online February 24, 2025. 46 (5), 537-539. DOI: 10.1017/ice.2025.17. (Corresponding Author)
39. Saito H, Nourollahi S, Alsharif MN, Bahadori B, Tjoa T, Mauricio A, Bethlahmy J, Chang J, Rashid S, Nelson EL, Van Etten RA, Armendariz L, Torres V, Masson S, Esteves M, Saavedra R, Singh RD, and Gohil SK. Improving central line-associated bloodstream infection prevention practices in oncology clinic patients: mobile-app based surveillance & response. Infection Control & Hospital Epidemiology. Published online April 10, 2025. 46 (5), 465-471. DOI: 10.1017/ice.2025.16. (Corresponding Author)
40. Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, Mauricio A, Sljivo S, Rahm R, Roemer K, Cooper WS, McLean LE, Nickolay NG, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith KN, Meador B, Froman A, Eibensteiner K, Hayden MK, Kubiak DW, Burks C, Burgess LH, Calderwood MS, Perlin JB, Platt R, and Huang SS. Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection: The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial. JAMA Internal Medicine. Published online April 10, 2025. DOI: 10.1001/jamainternmed.2025.0887. (Corresponding Author)
a. Editorial: Hasegawa S, Livorsi DJ. Electronic Stewardship Prompts—Exploring the Why Behind the What. JAMA Netw Open. 2025;8(4):e2512634. doi:10.1001/jamanetworkopen.2025.12634
41. Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, Mauricio A, Sljivo S, Rahm R, Roemer K, Cooper WS, McLean LE, Nickolay NG, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith KN, Meador B, Froman A, Eibensteiner K, Hayden MK, Kubiak DW, Burks C, Burgess LH, Calderwood MS, Perlin JB, Platt R, Huang SS. Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal Infection: The INSPIRE 4 Cluster Randomized Clinical Trial. JAMA Surgery. Published online April 10, 2025. DOI: 10.1001/jamasurg.2025.1108. (Corresponding Author)
a. Invited Commentary: Brown JB. Cutting the Antibiotic Spectrum for Low-Risk Abdominal Infection. JAMA Surg. Published online April 10, 2025. doi:10.1001/jamasurg.2025.1107
42. Gohil SK, Septimus E, Kleinman K, Avery TR, Varma N, Sands KE, Mauricio A, Poland RE, Guy J, Platt R and Huang, SS. Initial Antibiotic Selection Strategy and Subsequent Antibiotic Use—Insights From the INSPIRE Trials. JAMA. Published online July 17, 2025. 334(12), pp. 1107-1109. doi:10.1001/jama.2025.11256.
2. Yano, M. Gohil, S.K., Coleman, R., Pirofski, L. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance quorum sensing. mBio 2(5):e00176-11. 2011
3. Gohil, S.K., Heo, M., Schoenbaum, E., Pirofski, L. CD8+ T cells and Risk for Bacterial Pneumonia and All-Cause Mortality in HIV-Infected Women. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):191-8. (Corresponding Author)
4. Rohatgi, S., Gohil, S.K., Kuniholm, M., Schultz, H., Dufauda, C., Armourd, K., Badrie, S., Mailliard, R., Pirofski, L. Fc gamma receptor 3A Polymorphism and Risk for HIV-associated Cryptococcal Disease. mBio, 4(5):e00573-13. 2013
5. Rhee, C, Gohil, S.K., Klompas, M. Regulatory Mandates for Sepsis Care – Reasons for Caution. New England Journal of Medicine. 370:1673-1676. May 1, 2014.
6. Gohil, S.K., Datta, R., Chenghua, C., Phelan, M., Nguyen, V., Rowther, A., Huang, S. Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates. Clinical Infectious Diseases. 2015 Oct 15;61(8):1235-43. (Corresponding Author)
7. Gohil, S.K., Scott, S., Quan, K., Huang, S. Marked Reduction in Compliance with Central Line Insertion Practices (CLIP) When Accounting for Missing CLIP Data and Incomplete Capture of Lines. American Journal of Infection Control. 2015 Oct 27. pii: S0196-6553(15)00980-3. (Corresponding Author)
8. Gohil, S.K., Okubo, S., Klish, S., Huang, S., Zahn, M. Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention. Clinical Infectious Diseases. 2016 Jan 15;62(2):166-72. (Corresponding Author)
9. Gohil, S.K., Chenghua, C., Phelan, M., Rhee, C., Platt, R., Huang, S. Impact of Policies on the Rise of Sepsis Incidence, 2000-2010. Clinical Infectious Diseases. 2016 Mar 15;62 (6): 695-703. (Corresponding Author).
10. Madeline, T., Nori, P., Wenzhu, M., Zukowski, E., Gohil, S.K., Sarwar, U., Weston, G., Urelly, R., Palombelli, M., Pierino, F., Parsons, V., Ehrlich, A., Ostrowsky, B., Corpuz, M., Piroski, L. Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on AllCause
30-Day Hospital Readmissions. Open Forum Infectious Diseases. 2017 May; DOI: 10.1093/ofid/ofx097.
11. Gohil, S.K., Singh, R., Chang, J, Gombosev, A., Tjoa, T., Zahn, M., Steger, P., Huang, S.S. Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, CA, and support for early regional strategies to limit spread. American Journal of Infection Control. 2017 July; DOI: 10.1016/j.ajic.2017.06.004. (Corresponding Author)
12. Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2017;23(1):48.e9-.e16.
13. Singh, RD, Jernigan, JA, Slayton, R, Stone, ND, McKinnell, JA, Miller, LG, Kleinman, K, Heim, L, Dutciuc, TD, Estevez, M, Gussin, G, Chang, J, Peterson, EM, Evans, K, Bruce Y Lee, Lee, BY, Mueller, LE, Bartsch, SM, Zahn, M, Janssen, L, Weinstein, RA, Hayden, MA, Gohil, SK, Park, S, Tam, S, Saavedra, R, Yamaguchi, Y, Custodio, H, Nguyen, J, Tjoa, T, He, J, O’Donnell, K, Coady, MH, Platt, R, Huang, SS. CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program, The CDC SHIELD Orange County Project – Baseline Multi Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region, Open Forum Infectious Diseases, Volume 4, Issue suppl_1, Fall 2017, Pages S46 S47, https://doi.org/10.1093/ofid/ofx162.109
14. McKinnell, JA, Miller, LG, Singh, RD, Mendez, J, Franco, R, Gussin, G, Chang, J, Dutciuc, TD, Saavedra, R, Kleinman, K, Peterson, EM, Evans, Heim, L, Miner, A, Estevez, M, Custodio, H, Yamaguchi, S, Nguyen, J, Varasteh, A, Launer, B, Agrawal, S, Tjoa, T, He, J, Park, S, Tam, S, Gohil, SK, Stone, ND, Steinberg, K, Montgomery, M, Beecham, N, Huang, SS. When a Home is Not a Home: MultiDrug-Resistant Organism (MDRO) Colonization and Environmental Contamination in 28 Nursing Homes (NHs), Open Forum Infectious Diseases, Volume 4, Issue suppl_1, Fall 2017, Pages S42–S43, https://doi.org/10.1093/ofid/ofx162.103
15. Quan KA, Yim J, Merrill DG, Khusbu U, Madey K, Dickey L, Dangodara AA, Rudkin SE, O’Brien M, Thompson D, Parekh N, Albers CG, Wilson WC, Thrupp L, Bittencourt, CE, Huang, SS, Gohil, SK. Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing. Infection Control and Hospital Epidemiology. 2018 May; 39(5): 625–627. (Corresponding Author)
16. McKinnell, JA, Singh, RD, Miller, LG, Saavedra, R, Heim, L, Gussin, G, Lewis, B, Estevez, M, Catuna, TD, Mouth, K, Lee, E, He, J, Kleinman, K, Shimabukuro, J, Evans, K, Bittencourt, C, Baesu, C, Gohil, SK, Park, S, Tam, S, Robinson, PA, Slayton, R, Stone, ND, Jernigan, JA, Zahn, M, Janssen, L, ODonnell, K, Weinstein, RA, Hayden, MA, Lee, BY, Mueller, LE, Bartsch, SM, Peterson, EM, Huang, SS. The SHIELD Orange County Project: A Decolonization Strategy in 35 Hospitals and Nursing Homes Reduces Multi-Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region, Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Pages S23–S24, https://doi.org/10.1093/ofid/ofz359.052
17. McKinnell, JA, Singh, RD, Miller, LG, Kleinman, K, Gussin, G, He, J, Saavedra, R, Dutciuc, TD, Estevez, M, Chang, J, Heim, L, Yamaguchi, S, Custodio, H, Gohil, SK…. Huang, SS. The SHIELD Orange County Project –Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California. Clinical Infectious Diseases. Clinical Infectious Diseases, Volume 69, Issue 9, 1 November 2019, Pages 1566–1573, https://doi.org/10.1093/cid/ciz119
18. Gohil, SK, Yim, J, Quan, K, Espinoza, M, Thompson, DJ, Kong, AP, Bahadori, B, Tjoa, T, Paiji, C, Rudkin, S, Rashid, S, Hong, SS, Dickey, L, Alsharif, MN, Wilson, WC, Amin, AN, Chang, J, Khusbu, U, and Huang, SS. Impact of a Central Line Insertion Site Assessment (CLISA) Score on Localized Insertion Site Infection to Prevent Central Line Associated Bloodstream Infection. Infection Control and Hospital Epidemiology. 2019 Nov 8:1-8. (Corresponding Author)
19. Calderwood, M. S., Deloney, V. M., Anderson, D. J., Cheng, V. C. C., Gohil, SK, Kwon, J. H., Mody, L., Monsees, E., Vaughn, V. M., Wiemken, T. L., Ziegler, M. J., & Lofgren, E. (2020). Policies and practices of SHEA Research Network hospitals during the COVID-19 pandemic. Infection Control and Hospital Epidemiology, 41(10), 1127-1135. https://doi.org/10.1017/ice.2020.303
20. Mody, L, Akinboyo, IC, Babcock, HM, Bischoff, WE, Cheng, VC, Chiotos, K, Claeys, KC, Coffey, KC, Diekema, DJ, Donskey, CJ, Ellingson, KD, Gilmartin, HM, Gohil, SK, Harris, AD, Keller, SK, Klei, EY, Krein, SL, Kwon, JH, Lauring, AS, Livorsi, DJ, Lofgren, ET, Merrill, K, Milstone, A, Monsees, EA, Morgan, DJ, Perri, LP, Pfeiffer, CD, Rock, C, Saint, S, Sickbert-Bennett ,E, Skelton, F, Suda, KJ, Talbot, TR, Vaughn VM, Weber, DJ, Wiemken, TL, Yassin. MH, Ziegler MJ, Anderson, DJ, SHEA Research Committee. COVID-19 Research Agenda for Healthcare Epidemiology. Infection Control and Hospital Epidemiology. 2021 Jan 25;1-81. doi: 10.1017/ice.2021.25.
21. Gohil, SK, Huang, SS. Community COVID-19 Incidence and Health Care Personnel COVID-19 Seroprevalence. JAMA Netw Open. 2021 Mar 1;4(3):e211575. doi: 10.1001/jamanetworkopen.2021.1575. (Corresponding Author)
22. Srinivasan, V, Gohil, SK, Abeles, SR, Yokoe, DS, Cohen, SH, Ramirez-Avila, L, Prabaker, K, de St. Maurice, AM. Finding a needle in a haystack: The hidden costs of asymptomatic testing in a low incidence setting. Infect Control. Infection Control & Hospital Epidemiology, October, 2021, 1–2. doi:10.1017/ice.2021.288.
23. Gohil, SK, Quan, KA, Madey, KM, King-Adelsohn, S, Tifrea, D, Crews, BO, Monuki, ES, Khan, S, Schubl, SD, Bittencourt, CE, Detweiler, N, Chang, W, Willis, L, Khusbu, U, Saturno, A, Rezk, SA, igueroa, C, Edwards, R, Jain, A, Assis, R, Felgner, P, Hsieh, L, Forthal, D, Wilson, WC, Stamos, MJ, Huang, SS. COVID-19 Seroprevalence Among Healthcare Professionals Accounting for Coworker Exposures and Community Characteristics. Antimicrob Resist Infect Control. 2021 Nov 22;10(1):163. doi: 10.1186/s13756-021-01031-5. (Corresponding Author)
24. Gohil, SK, Olenslager, K, Quan K, Dastur, C, Afsar, N, Chang, W, Huang, SS. Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination. JAMA Netw Open. Jul, 2021;4(7):e2115980. doi:10.1001/jamanetworkopen.2021.15980 (Corresponding Author)
25. Gussin GM, McKinnell JA, Tjoa T, Wedlock PT, He J, Chang J, Gohil SK, Miller LG, Huang SS, Lee BY. Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a Region. JAMA Netw Open. 2021 Aug 2;4(8):e2119212. doi: 10.1001/jamanetworkopen.2021.19212. PMID: 34347060; PMCID: PMC8339938
26. Mody L, Akinboyo IC, Babcock HM, Bischoff WE, Cheng VC, Chiotos K, Claeys KC, Coffey KC, Diekema DJ, Donskey CJ, Ellingson KD, Gilmartin HM, Gohil SK, Harris AD, Keller SC, Klein EY, Krein SL, Kwon JH, Lauring AS, Livorsi DJ, Lofgren ET, Merrill K, Milstone AM, Monsees EA, Morgan DJ, Perri LP, Pfeiffer CD, Rock C, Saint S, Sickbert-Bennett E, Skelton F, Suda KJ, Talbot TR, Vaughn VM, Weber DJ, Wiemken TL, Yassin MH, Ziegler MJ, Anderson DJ; SHEA Research Committee. Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. Infect Control Hosp Epidemiol. 2022 Feb;43(2):156-166. doi: 10.1017/ice.2021.25. PMID: 33487199; PMCID: PMC8160487.
27. Waldman SE, Buehring T, Escobar DJ, Gohil SK, Gonzales R, Huang SS, Olenslager K, Prabaker KK, Sandoval T, Yim J, Yokoe DS, Cohen SH. Secondary Cases of Delta Variant Coronavirus Disease 2019 Among Vaccinated Healthcare Workers With Breakthrough Infections is Rare. Clin Infect Dis. 2022 Aug 24;75(1):e895-e897. doi: 10.1093/cid/ciab916. PMID: 34694358; PMCID: PMC8574310.
28. Quan KA, Sater MRA, Uy C, Clifton-Koeppel R, Dickey LL, Wilson W, Patton P, Chang W, Samuelson P, Lagoudas GK, Allen T, Merchant L, Gannotta R, Bittencourt CE, Soto JC, Evans KD, Blainey PC, Murray J, Shelton D, Lee HS, Zahn M, Wolfe J, Madey K, Yim J, Gohil SK, Grad YH, Huang SS. Epidemiology and genomics of a slow outbreak of methicillin-resistant Staphyloccus aureus (MRSA) in a neonatal intensive care unit: Successful chronic decolonization of MRSA-positive healthcare personnel. Infect Control Hosp Epidemiol. 2022 Jun 16:1-8. doi: 10.1017/ice.2022.133. Epub ahead of print. PMID: 35706396.
29. Hsi JB, Singh RD, Pedroza R, Gussin GM, Tjoa TT, Gohil SK. Impact of Alzheimer's disease and related dementias (ADRD) on the quality of room cleaning in nursing homes. Infect Control Hosp Epidemiol. 2023 Feb 9:1-3. doi: 10.1017/ice.2023.7. Epub ahead of print. PMID: 36756757.
30. Gohil SK, de St. Maurice A, Yokoe D, Torriani FJ, Grein JD, Robinson PA, Mabalot S, Park J, Pedrani P, Platt R, Huang SS. Assessing Past vs Present COVID-19 Infection: A Survey of Criteria for Discontinuing Precautions in Asymptomatic Patients. Infect Control Hosp Epidemiology. 2024 Feb;45(2):237-240. doi: 10.1017/ice.2023.147. Epub 2023 Sep 13. (Corresponding Author)
31. Gohil SK, Septimus E, Sands KE, Blanchard EJ, Moody J, de St. Maurice A, Yokoe D, Kwon J, Grein J, Cohen S, Uslan D, Milind V, Mauricio A, Mabalot S, Coady MD, Selsebil S, Smith K, Carver B, Poland R, Perlin J, Platt J, Huang SS. COVID-19 Infection Prevention Practices That Exceed CDC Guidance: Balancing Extra Caution Against Impediments to Care. Infection Control & Hospital Epidemiology (2023), 44, 2074–2077. doi:10.1017/ice.2023.89. (Corresponding Author)
32. Rhee Y, Hayden MK, Schoeny M, Baker AW, Baker MA, Gohil S, Rhee C, Talati NJ, Warren DK, Welbel S, Lolans K, Bahadori B, Bell PB, Bravo H, Dangana T, Fukuda C, Habrock Bach T, Nelson A, Simms AT, Tolomeo P, Wolf R, Yelin R, Lin MY; CDC Prevention Epicenters Program. Impact of measurement and feedback on chlorhexidine gluconate bathing among intensive care unit patients: A multicenter study. Infect Control Hosp Epidemiol. 2023 Sep;44(9):1375-1380. doi: 10.1017/ice.2023.177. Epub 2023 Sep 13. PMID: 37700540.
33. Miller LG, McKinnell JA, Singh RD, Gussin GM, Kleinman K, Saavedra R, Mendez J, Catuna TD, Felix J, Chang J, Heim L, Franco R, Tjoa T, Stone ND, Steinberg K, Beecham N, Montgomery J, Walters D, Park S, Tam S, Gohil S, Robinson PA, Estevez M, Lewis B, Shimabukuro JA, Tchakalian G, Minor A, Torres C, Evans KD, BA, Bittencourt CE, He J, Lee E, Nedelcu C, Lu J, Agrawal S, Sturdevant SG, Peterson E, Huang SS. Nursing Home Decolonization for Infection and Hospitalization Prevention. N Engl J Med 2023 Nov 9;389(19):1766-1777. doi: 10.1056/NEJMoa2215254. Epub 2023 Oct 10. PMID: 37815935
34. Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, Rahm R, Cooper WS, Cooper M, McLean LE, Nickolay NG, Weinstein RA, Burgess LH, M H Coady MH, Rosen E, Sljivo S, Sands KE, Moody J, Vigeant J, Rashid S, Gilbert RF, Smith KN, Carver B, Poland RE, Hickok J, Sturdevant SG, Calderwood MS, Weiland A, Kubiak DW, Reddy S, Neuhauser MM, Srinivasan A, Jernigan JA, Hayden MK, Gowda A, Eibensteiner K, Wolf R, Perlin JB, Platt R, Huang SS. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial. JAMA. Published online April 19, 2024. doi:10.1001/jama.2024.6248. (Corresponding Author)
a. Editorial: Malani AN, Malani PN. Harnessing the Electronic Health Record to Improve Empiric Antibiotic Prescribing. JAMA. 2024;331(23):1993–1994. doi:10.1001/jama.2024.6554
35. Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, Rahm R, Cooper WS, Cooper M, McLean LE, Nickolay NG, Weinstein RA, Burgess LH, M H Coady MH, Rosen E, Sljivo S, Sands KE, Moody J, Vigeant J, Rashid S, Gilbert RF, Smith KN, Carver B, Poland RE, Hickok J, Sturdevant SG, Calderwood MS, Weiland A, Kubiak DW, Reddy S, Neuhauser MM, Srinivasan A, Jernigan JA, Hayden MK, Gowda A, Eibensteiner K, Wolf R, Perlin JB, Platt R, Huang SS. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial. JAMA. Published online April 19, 2024. doi:10.1001/jama.2024.6259. (Corresponding Author)
a. Summary and Comment: Winawer NH. Your Patient Doesn’t Need a Broad-Spectrum Antibiotic. NEJM Journal Watch. 2024. https://www.jwatch.org/na57398/2024/05/21/your-patient-doesnt-need-broad-spectrum-antibiotic
36. Kwon JH, Advani SD, Branch-Elliman W, Braun BI, Cheng VC, Chiotos K, Douglas P, Gohil SK, Keller SC, Klein EY, Krein SL, Lofgren ET, Merrill K, Moehring RW, Monsees E, Perri L, Scaggs Huang F, Shelly MA, Skelton F, Spivak ES, Sreeramoju PV, Suda KJ, Ting JY, Weston GD, Yassin MH, Ziegler MJ, and Mody L. A call to action: the SHEA research agenda to combat healthcare-associated infections. Infection Control & Hospital Epidemiology. 2024;45(9):1023-1040. doi:10.1017/ice.2024.125
37. Singh RD, Bahadori B, Tjoa T, Alsharif MN, Nourollahi S, Chang J, Mauricio A, Bethlahmy J, Rashid S, Saavedra R, Ashbaugh IY, Tam S, and Gohil SK. A telehealth approach to central line-associated bloodstream infection prevention activities in nursing homes: the SAFER lines program. Infection Control & Hospital Epidemiology. Published online February 3, 2025, 46 (3), 236-242. DOI: 10.1017/ice.2024.203. (Corresponding Author)
38. Mauricio A, Hsi JB, Tjoa T, Singh RD, Nourollahi S, Saavedra R, Bahadori B, Alsharif MN, Tam S, Chang J, Rashid S, and Gohil SK. Failure of timely removal of central and peripheral venous catheters after antibiotic therapy in nursing homes. Infection Control & Hospital Epidemiology. Published online February 24, 2025. 46 (5), 537-539. DOI: 10.1017/ice.2025.17. (Corresponding Author)
39. Saito H, Nourollahi S, Alsharif MN, Bahadori B, Tjoa T, Mauricio A, Bethlahmy J, Chang J, Rashid S, Nelson EL, Van Etten RA, Armendariz L, Torres V, Masson S, Esteves M, Saavedra R, Singh RD, and Gohil SK. Improving central line-associated bloodstream infection prevention practices in oncology clinic patients: mobile-app based surveillance & response. Infection Control & Hospital Epidemiology. Published online April 10, 2025. 46 (5), 465-471. DOI: 10.1017/ice.2025.16. (Corresponding Author)
40. Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, Mauricio A, Sljivo S, Rahm R, Roemer K, Cooper WS, McLean LE, Nickolay NG, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith KN, Meador B, Froman A, Eibensteiner K, Hayden MK, Kubiak DW, Burks C, Burgess LH, Calderwood MS, Perlin JB, Platt R, and Huang SS. Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection: The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial. JAMA Internal Medicine. Published online April 10, 2025. DOI: 10.1001/jamainternmed.2025.0887. (Corresponding Author)
a. Editorial: Hasegawa S, Livorsi DJ. Electronic Stewardship Prompts—Exploring the Why Behind the What. JAMA Netw Open. 2025;8(4):e2512634. doi:10.1001/jamanetworkopen.2025.12634
41. Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, Mauricio A, Sljivo S, Rahm R, Roemer K, Cooper WS, McLean LE, Nickolay NG, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith KN, Meador B, Froman A, Eibensteiner K, Hayden MK, Kubiak DW, Burks C, Burgess LH, Calderwood MS, Perlin JB, Platt R, Huang SS. Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal Infection: The INSPIRE 4 Cluster Randomized Clinical Trial. JAMA Surgery. Published online April 10, 2025. DOI: 10.1001/jamasurg.2025.1108. (Corresponding Author)
a. Invited Commentary: Brown JB. Cutting the Antibiotic Spectrum for Low-Risk Abdominal Infection. JAMA Surg. Published online April 10, 2025. doi:10.1001/jamasurg.2025.1107
42. Gohil SK, Septimus E, Kleinman K, Avery TR, Varma N, Sands KE, Mauricio A, Poland RE, Guy J, Platt R and Huang, SS. Initial Antibiotic Selection Strategy and Subsequent Antibiotic Use—Insights From the INSPIRE Trials. JAMA. Published online July 17, 2025. 334(12), pp. 1107-1109. doi:10.1001/jama.2025.11256.
Grants
UCI School of Medicine Faculty Research Award
K-L2 ICTS
R01-AHRQ
NIH NRSA Training Grant (5T32)
2015-2018 AHRQ (R01-RFA-HS-024424)
2015-2018 CDC SHIELD OC SHEPheRD Task Order 2015-005
2018-2019 Department of Medicine Chair’s Research Grant
2016-2020 CDC Task Force (SHEPheRD Task Order 200-2011-42037)
2020-2021 Orange County Health Care Agency & CalOptima
2022-2023 Institute for Clinical & Translational Science UM1 Planning Grant
2022-2023 ICCRP Office of the Provost and Executive Vice Chancellor Funding Award
2021-2022 CalOptima (Orange County Medicaid)
2022-2024 Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States (1 NU50CK000614-01)
2020-2025 National Institute of Health, NIAID (U01AI153005)
Professional Societies
Infectious Disease Society of America
Society for Healthcare Epidemiologists of America
Other Experience
Associate Professor, Infectious Diseases
University of California, Irvine 2012—Curr
University of California, Irvine 2012—Curr
Attending, Infectious Disease
Albert Einstein College of Medicine 2009—2010
Albert Einstein College of Medicine 2009—2010
Infectious Disease Research Fellow
Albert Einstein College of Medicine 2006—2009
Albert Einstein College of Medicine 2006—2009
Research Centers
Health Policy Research Institute
Link to this profile
https://faculty.uci.edu/profile/?facultyId=5866
https://faculty.uci.edu/profile/?facultyId=5866
Last updated
01/20/2026
01/20/2026